| NCT ID | NCT04329234 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Seoul National University Bundang Hospital |
| Condition | Acute Heart Failure |
| Study Type | OBSERVATIONAL |
| Enrollment | 10,000 participants |
| Start Date | 2018-10-01 |
| Primary Completion | 2027-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 10,000 participants in total. It began in 2018-10-01 with a primary completion date of 2027-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
KorHF III is a multi-center, nationwide, prospective registry of the Korean Society of Heart Failure, which enrolls patients with acute heart failure in Korea. The aim of this registry is to analyze the etiology, treatment, treatment, and prognosis to develop strategies for managing acute heart failure.
Eligibility Criteria
All consecutive hospitalized adult heart failure patients who fulfill one of 1-3 and 4 Inclusion Criteria: 1. Symptoms of heart failure 2. Signs of heart failure 3. Lung congestion in Chest-x-ray 4. Objective finding of structural and/or functional disorder of the heart or elevated natriuretic peptide levels Exclusion Criteria: 1. Patients younger than 18 years old 2. Patients who do no consent
Contact & Investigator
Frequently Asked Questions
Who can join the NCT04329234 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Acute Heart Failure. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT04329234 currently recruiting?
Yes, NCT04329234 is actively recruiting participants. Contact the research team at djchoi@snubh.org for enrollment information.
Where is the NCT04329234 trial being conducted?
This trial is being conducted at Seongnam, South Korea.
Who is sponsoring the NCT04329234 clinical trial?
NCT04329234 is sponsored by Seoul National University Bundang Hospital. The trial plans to enroll 10,000 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.